{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T21:07:09Z","timestamp":1793308029234,"version":"4.5.0"},"reference-count":53,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Premenstrual disorders (PMDs), including premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD), are associated with significant physical and psychological burdens. However, their associations with quality of life (QOL) remain insufficiently studied, particularly with limited consideration of comorbidities and potential confounders.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To assess the QOL among women with PMDs compared with women without PMDs in Sweden.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This cross-sectional study included participants from the LifeGene cohort, a population-based longitudinal study with linkage to national health care registers. Participants were women aged 15 to 60 years. Data were collected from October 2009 to May 2018 and analyzed from June 2024 to January 2025.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n PMDs were ascertained using a modified Premenstrual Symptoms Screening Tool, supplemented by diagnoses recorded in Swedish health care registers.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n QOL was assessed using the EuroQol 5-Dimensions 3-Levels scale including 5 dimensions: mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. The primary outcome was the total QOL score, with additional analyses excluding the anxiety or depression and pain or discomfort dimensions. Associations between PMDs and total QOL score were evaluated using linear regression models, adjusting for age, socioeconomic status, and potential confounders. Analyses were further stratified by the history of comorbidities. PMS, PMDD, and each QOL dimension were also examined separately.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n In this study of 17\u202f284 women, at a mean (SD) age of 32.4 (8.1) years, 1813 women (10.5%) met the criteria for PMDs. Women with PMDs had significantly lower QOL compared with those without PMDs (mean\n z<\/jats:italic>\n score difference: 0.21; 95% CI, 0.17-0.26). This association persisted in the prospective analysis (mean\n z<\/jats:italic>\n score difference: 0.34; 95% CI, 0.24-0.45) or after excluding the anxiety or depression and pain or discomfort dimension. PMDD appeared to have a stronger association with reduced QOL than PMS. In the analysis of individual QOL dimensions, PMDs were strongly associated with endorsing anxiety or depression (PR, 1.31; 95% CI, 1.25-1.37) and pain or discomfort (PR, 1.14; 95% CI, 1.08-1.21).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cross-sectional study of women in Sweden, PMDs, particularly PMDD, were significantly associated with reduced QOL, independent of potential confounders and comorbidities. These findings highlighted the need for both health care and social support to better manage the disease and improve the overall QOL of affected women.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.33823","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T15:00:20Z","timestamp":1758639620000},"page":"e2533823","source":"Crossref","is-referenced-by-count":5,"title":["Premenstrual Disorders and Quality of Life in Sweden"],"prefix":"10.1001","volume":"8","author":[{"given":"Qiwei","family":"Wang","sequence":"first","affiliation":[{"name":"Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecka","family":"Keijser","sequence":"additional","affiliation":[{"name":"Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Yu","sequence":"additional","affiliation":[{"name":"Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elgeta","family":"Hysaj","sequence":"additional","affiliation":[{"name":"Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"H\u00e4gg","sequence":"additional","affiliation":[{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Unnur A.","family":"Valdimarsd\u00f3ttir","sequence":"additional","affiliation":[{"name":"Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"},{"name":"Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden"},{"name":"Center of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjav\u00edk, Iceland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Bertone-Johnson","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, School of Public Health and Health Sciences, University of Massachusetts Amherst"},{"name":"Department of Health Promotion and Policy, School of Public Health and Health Sciences, University of Massachusetts Amherst"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurate","family":"Aleknaviciute","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Erasmus MC University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghao","family":"Lu","sequence":"additional","affiliation":[{"name":"Unit of Integrative Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"issue":"9619","key":"zoi250949r1","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/S0140-6736(08)60527-9","article-title":"Premenstrual syndrome.","volume":"371","author":"Yonkers","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"zoi250949r2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ajog.2017.05.045","article-title":"Premenstrual disorders.","volume":"218","author":"Yonkers","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"zoi250949r3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S0306-4530(03)00099-4","article-title":"Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis.","volume":"28","author":"Freeman","year":"2003","journal-title":"Psychoneuroendocrinology"},{"issue":"2","key":"zoi250949r4","doi-asserted-by":"publisher","first-page":"164","DOI":"10.4103\/0019-5545.183796","article-title":"Prevalence of premenstrual syndrome and premenstrual dysphoric disorder among college students of Bhavnagar, Gujarat.","volume":"58","author":"Raval","year":"2016","journal-title":"Indian J Psychiatry"},{"issue":"5","key":"zoi250949r5","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2165\/00019053-200523050-00003","article-title":"Effects of antidepressants on quality of life in women with premenstrual dysphoric disorder.","volume":"23","author":"Freeman","year":"2005","journal-title":"Pharmacoeconomics"},{"issue":"12","key":"zoi250949r6","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/aje\/kwv159","article-title":"Premenstrual syndrome and subsequent risk of hypertension in a prospective study.","volume":"182","author":"Bertone-Johnson","year":"2015","journal-title":"Am J Epidemiol"},{"issue":"1","key":"zoi250949r7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12916-021-01989-4","article-title":"Clinical indications of premenstrual disorders and subsequent risk of injury: a population-based cohort study in Sweden.","volume":"19","author":"Yang","year":"2021","journal-title":"BMC Med"},{"issue":"2","key":"zoi250949r8","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00737-020-01054-8","article-title":"Suicidality in women with premenstrual dysphoric disorder: a systematic literature review.","volume":"24","author":"Osborn","year":"2021","journal-title":"Arch Womens Ment Health"},{"key":"zoi250949r9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0306-4530(03)00098-2","article-title":"The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS\/PMDD).","volume":"28","author":"Halbreich","year":"2003","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"zoi250949r10","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/aje\/kwv456","article-title":"Diverse cumulative impact of chronic diseases on physical health-related quality of life: implications for a measure of multimorbidity.","volume":"184","author":"Wei","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"2","key":"zoi250949r11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.2165\/11533750-000000000-00000","article-title":"Explorative evaluation of the impact of premenstrual disorder on daily functioning and quality of life.","volume":"3","author":"Heinemann","year":"2010","journal-title":"Patient"},{"issue":"7","key":"zoi250949r12","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1177\/14034948211047776","article-title":"A snapshot of an eCohort: a comparison of the LifeGene population at baseline with the Swedish general population.","volume":"50","author":"Rissanen","year":"2022","journal-title":"Scand J Public Health"},{"key":"zoi250949r13","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register.","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"issue":"5","key":"zoi250949r14","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1093\/fampra\/cmt033","article-title":"Most common diseases diagnosed in primary care in Stockholm, Sweden, in 2011.","volume":"30","author":"W\u00e4ndell","year":"2013","journal-title":"Fam Pract"},{"issue":"7","key":"zoi250949r15","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register\u2014opportunities for pharmacoepidemiological research and experience from the first six months.","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"zoi250949r17","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/140349489001800209","article-title":"A quality study of a medical birth registry.","volume":"18","author":"Cnattingius","year":"1990","journal-title":"Scand J Soc Med"},{"issue":"2","key":"zoi250949r19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the Swedish total population and their use in medical research.","volume":"31","author":"Ludvigsson","year":"2016","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"zoi250949r20","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10654-019-00511-8","article-title":"The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research.","volume":"34","author":"Ludvigsson","year":"2019","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"zoi250949r21","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00737-003-0018-4","article-title":"The premenstrual symptoms screening tool (PSST) for clinicians.","volume":"6","author":"Steiner","year":"2003","journal-title":"Arch Womens Ment Health"},{"issue":"1","key":"zoi250949r22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00737-010-0201-3","article-title":"Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus.","volume":"14","author":"O\u2019Brien","year":"2011","journal-title":"Arch Womens Ment Health"},{"issue":"1","key":"zoi250949r23","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1055\/s-0037-1608672","article-title":"Premenstrual syndrome diagnosis: a comparative study between the daily record of severity of problems (DRSP) and the premenstrual symptoms screening tool (PSST).","volume":"40","author":"Henz","year":"2018","journal-title":"Rev Bras Ginecol Obstet"},{"issue":"4","key":"zoi250949r24","doi-asserted-by":"publisher","first-page":"603","DOI":"10.5498\/wjp.v12.i4.603","article-title":"Dimensional (premenstrual symptoms screening tool) vs categorical (mini diagnostic interview, module U) for assessment of premenstrual disorders.","volume":"12","author":"Chamali","year":"2022","journal-title":"World J Psychiatry"},{"key":"zoi250949r25","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.jad.2024.08.032","article-title":"Association between severe premenstrual disorders and change of romantic relationship: a prospective cohort of 15,606 women in Sweden.","volume":"364","author":"Westermark","year":"2024","journal-title":"J Affect Disord"},{"issue":"11","key":"zoi250949r27","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/0277-9536(94)90005-1","article-title":"Test-retest reliability of health state valuations collected with the EuroQol questionnaire.","volume":"39","author":"van Agt","year":"1994","journal-title":"Soc Sci Med"},{"issue":"3","key":"zoi250949r28","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF00435221","article-title":"Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire.","volume":"2","author":"Brazier","year":"1993","journal-title":"Qual Life Res"},{"issue":"7","key":"zoi250949r29","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s11136-006-0059-z","article-title":"Measuring health-related quality of life in bipolar disorder: relationship of the EuroQol (EQ-5D) to condition-specific measures.","volume":"15","author":"Hayhurst","year":"2006","journal-title":"Qual Life Res"},{"issue":"7","key":"zoi250949r30","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1055\/s-2006-940125","article-title":"Discriminative ability, construct validity and sensitivity to change of the EQ-5D quality of life questionnaire in paranoid schizophrenia.","volume":"33","author":"Konnopka","year":"2006","journal-title":"Psychiatr Prax"},{"issue":"2","key":"zoi250949r32","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s11136-013-0496-4","article-title":"Swedish experience-based value sets for EQ-5D health states.","volume":"23","author":"Burstr\u00f6m","year":"2014","journal-title":"Qual Life Res"},{"issue":"1","key":"zoi250949r33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00737-003-0027-3","article-title":"Premenstrual dysphoric disorder and psychiatric co-morbidity.","volume":"7","author":"Kim","year":"2004","journal-title":"Arch Womens Ment Health"},{"issue":"22","key":"zoi250949r34","doi-asserted-by":"publisher","first-page":"12022","DOI":"10.3390\/ijerph182212022","article-title":"Anxiety, depression and quality of life-a systematic review of evidence from longitudinal observational studies.","volume":"18","author":"Hohls","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"3","key":"zoi250949r35","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/(SICI)1520-7560(199905\/06)15:3<205::AID-DMRR29>3.0.CO;2-O","article-title":"Quality of life and diabetes.","volume":"15","author":"Rubin","year":"1999","journal-title":"Diabetes Metab Res Rev"},{"issue":"3","key":"zoi250949r36","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/08964289.2023.2202847","article-title":"Health related quality of life and cardiovascular risk factors.","volume":"50","author":"Kontoangelos","year":"2024","journal-title":"Behav Med"},{"key":"zoi250949r37","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/CLEP.S282475","article-title":"Adaptation of the Charlson comorbidity index for register-based research in Sweden.","volume":"13","author":"Ludvigsson","year":"2021","journal-title":"Clin Epidemiol"},{"issue":"1","key":"zoi250949r38","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12916-022-02275-7","article-title":"ssociation between adverse childhood experiences and premenstrual disorders: a cross-sectional analysis of 11,973 women.","volume":"20","author":"Yang","year":"2022","journal-title":"BMC Med"},{"key":"zoi250949r39","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jad.2014.02.004","article-title":"The influence of childhood abuse, adult stressful life events and temperaments on depressive symptoms in the nonclinical general adult population.","volume":"158","author":"Nakai","year":"2014","journal-title":"J Affect Disord"},{"issue":"3","key":"zoi250949r40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173806","article-title":"Does personality affect health-related quality of life? a systematic review.","volume":"12","author":"Huang","year":"2017","journal-title":"Plos One"},{"key":"zoi250949r41","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108558","article-title":"Health-related quality of life of alcohol use disorder with co-occurring conditions in the us population.","volume":"221","author":"Wittenberg","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"zoi250949r42","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jad.2021.06.017","article-title":"Patterns of premenstrual syndrome and depression symptoms in chinese female university students: results of a latent profile analysis.","volume":"293","author":"Hou","year":"2021","journal-title":"J Affect Disord"},{"issue":"6","key":"zoi250949r43","first-page":"638","article-title":"Frequency of premenstrual dysphoric disorder (PMDD) and comparison of quality of life between female medical students with and without premenstrual dysphoric disorder.","volume":"33","author":"Mahmood","year":"2023","journal-title":"J Coll Physicians Surg Pak"},{"issue":"11","key":"zoi250949r44","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1007\/s11136-017-1642-1","article-title":"Reduction of quality-adjusted life years (QALYs) in patients with premenstrual dysphoric disorder (PMDD).","volume":"26","author":"Yamada","year":"2017","journal-title":"Qual Life Res"},{"key":"zoi250949r45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7525-10-1","article-title":"Health related quality of life among adolescents with premenstrual disorders: a cross sectional study.","volume":"10","author":"Delara","year":"2012","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"zoi250949r46","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4103\/ipj.ipj_106_22","article-title":"Prevalence of premenstrual syndrome and its effect on quality of work life in working women in South India.","volume":"32","author":"Maheshwari","year":"2023","journal-title":"Ind Psychiatry J"},{"issue":"11","key":"zoi250949r47","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1089\/jwh.2015.5636","article-title":"Association of premenstrual syndrome with blood pressure in young adult women.","volume":"25","author":"Bertone-Johnson","year":"2016","journal-title":"J Womens Health (Larchmt)"},{"issue":"3","key":"zoi250949r48","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1161\/01.CIR.101.3.329","article-title":"Essential hypertension. part I: definition and etiology.","volume":"101","author":"Carretero","year":"2000","journal-title":"Circulation"},{"issue":"4","key":"zoi250949r49","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3109\/00016349309068030","article-title":"Evidence for altered transcapillary fluid balance in women with the premenstrual syndrome.","volume":"72","author":"Tollan","year":"1993","journal-title":"Acta Obstet Gynecol Scand"},{"key":"zoi250949r50","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jad.2024.01.066","article-title":"The prevalence of premenstrual dysphoric disorder: systematic review and meta-analysis.","volume":"349","author":"Reilly","year":"2024","journal-title":"J Affect Disord"},{"issue":"1","key":"zoi250949r51","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1176\/appi.ajp.2016.15121510","article-title":"Toward the reliable diagnosis of DSM-5 premenstrual dysphoric disorder: the Carolina Premenstrual Assessment Scoring System (C-PASS).","volume":"174","author":"Eisenlohr-Moul","year":"2017","journal-title":"Am J Psychiatry"},{"issue":"1","key":"zoi250949r53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/jwh.2008.0932","article-title":"Premenstrual syndrome prevalence and fluctuation over time: results from a French population-based survey.","volume":"18","author":"Potter","year":"2009","journal-title":"J Womens Health (Larchmt)"},{"key":"zoi250949r16","unstructured":"National prescribed drug register. Socialstyrelsen. Accessed August 13, 2025. https:\/\/www.socialstyrelsen.se\/en\/statistics-and-data\/registers\/national-prescribed-drug-register\/"},{"key":"zoi250949r18","unstructured":"National medical birth register. Socialstyrelsen. Accessed August 13, 2025. https:\/\/www.socialstyrelsen.se\/en\/statistics-and-data\/registers\/national-medical-birth-register\/"},{"key":"zoi250949r26","unstructured":"F\u00f6rlossning RSlefko. Riktlinjer vid premenstruell dysforisk st\u00f6rning, PMDS. Janusinfo. Accessed January 4, 2025. https:\/\/janusinfo.se\/behandling\/expertgruppsutlatanden\/kvinnosjukdomarochforlossning\/kvinnosjukdomarochforlossning\/riktlinjervidpremenstruelldysforiskstorningpmds.5.6081a39c160e9b387319f3.html"},{"key":"zoi250949r31","unstructured":"Foundation? ER. EQ-5D-3L user guide [Internet]. EuroQol Research Foundation. Accessed August 13, 2025. https:\/\/euroqol.org\/wp-content\/uploads\/2023\/11\/EQ-5D-3LUserguide-23-07.pdf"},{"key":"zoi250949r52","unstructured":"Agency? EM. Guideline on the treatment of premenstrual dysphoric disorder (PMDD). European Medicines Agency. Accessed January 4, 2025. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-treatment-premenstrual-dysphoric-disorder-pmdd_en.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2839226\/wang_2025_oi_250949_1758037393.77711.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T15:00:25Z","timestamp":1758639625000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2839226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.33823","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]}}}